Osteopontin - a biomarker for organ damage in paediatric lupus?
- PMID: 23472880
- PMCID: PMC3672824
- DOI: 10.1186/ar4172
Osteopontin - a biomarker for organ damage in paediatric lupus?
Abstract
A growing body of literature has demonstrated that the multifunctional glycoprotein osteopontin (OPN), has a role in type I interferon (IFN) production and may be involved in systemic lupus erythematosus (SLE) pathogenesis. A recent report has provided further support for this, demonstrating an association between raised baseline circulating plasma osteopontin (cOPN) levels and IFN, and an elevation in cOPN prior to the onset of both increased cumulative disease and end-organ damage. These associations were most marked in paediatric SLE, implying that cOPN may be a useful biomarker of disease activity in childhood lupus.
Comment on
-
Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus.Arthritis Res Ther. 2013 Jan 23;15(1):R18. doi: 10.1186/ar4150. Arthritis Res Ther. 2013. PMID: 23343383 Free PMC article.
References
-
- Rullo OJ, Woo JM, Parsa MF, Hoftman AD, Maranian P, Elashoff DA, Niewold TB, Grossman JM, Hahn BH, McMahon M, McCurdy DK, Tsao BP. Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus. Arthritis Res Ther. 2013;15:R18. doi: 10.1186/ar4150. - DOI - PMC - PubMed
-
- Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H, Ashkar S. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol. 2002;72:752–761. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
